Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV
AIDS Research and Human Retroviruses · 2025
DOI: 10.1089/aid.2024.0067 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift AIDS Research and Human Retroviruses, 2025. Verfasst von Jesús Joaquín Hijona Elósegui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Ginecología y Obstetricia, Hospital Universitario Materno Infantil de Jaén, Jaén, Spain. Hauptthemen laut MEDLINE: HIV Infections, Papillomavirus Infections, Conservative Treatment, Vaginal Creams, Foams, and Jellies. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Infection with human immunodeficiency virus (HIV) shows a higher risk of infection by human papillomavirus (HPV). We aim to provide evidence about the effect of a Coriolus versicolor -based vaginal gel (Papilocare®) for treating HPV in women with HIV. Women ≥25 years coinfected by endocervical HPV and with low-grade abnormal cervicovaginal cytology were treated for 6 months with Papilocare in this observational, prospective, noncontrolled pilot study. Cytology, colposcopy, biopsy, hybrid capture test, and 5-point Likert scale were assessed to evaluate cervical lesions repair, HPV clearance, and changes in cervical reepithelization, respectively, at 6 months. Fifteen patients (25–54 years) were included. Overall HPV clearance and cytological normalization rates were 73.3% and 80.0%, respectively, and 55.6% of the abnormal colposcopies were normalized. Reepithelialization index improved in 66.7% of cases. Papilocare may be effective for managing endocervical HPV infection in patients living with HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Ginecología y Obstetricia, Hospital Universitario Materno Infantil de Jaén, Jaén, Spain.
- Servicio de Ginecología y Obstetricia, Hospital Universitario Torrecárdenas, GAEPI-VPH (Grupo Andaluz para el Estudio y la Prevención de la Infección por VPH), Almería, Spain.
ORCID-Profile: Jesús Joaquín Hijona Elósegui
Zitieren
APA
Hijona Elósegui, J. J., Carballo García, A. L., Fernández Rísquez, A. C., Presa Lorite, J. C., & Ruiz, G. F. (2025). Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2024.0067
Vancouver
Hijona Elósegui JJ, Carballo García AL, Fernández Rísquez AC, Presa Lorite JC, Ruiz GF. Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV. AIDS Research and Human Retroviruses. 2025. doi:10.1089/aid.2024.0067
BibTeX
@article{HijonaElsegui2025,
author = {Hijona Elósegui, Jesús Joaquín and Carballo García, Antonio Luis and Fernández Rísquez, Ana Cristina and Presa Lorite, Jesús Carlos and Ruiz, Gabriel Fiol},
title = {Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV},
journal = {AIDS Research and Human Retroviruses},
year = {2025},
doi = {10.1089/aid.2024.0067}
}
EUVIMED